All lobbying filings

MR. DAN CRIPPEN

MR. DAN CRIPPEN filed a Q4 report for AMGEN on February 18, 2026, reporting $100,000 in lobbying income.

Lobbying for AMGEN · Manufacture Pharmaceuticals

All filings by MR. DAN CRIPPEN · Everything AMGEN has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Feb 18, 2026

Income

$100,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Pharmacy

pharmacy rebates and discounts pharmacy R&D

Economics/Economic Development

pharmacy rebates and discounts

Government Issues

congressional procedure

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.